SCHEMBL30910779

SCHEMBL30910779

COC(=O)[C@H](C)NC(=O)[C@H](N)CCC(N)=O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 2/20 0.61
DPP8 Q6V1X1 2/20 0.61
DPP9 Q86TI2 2/20 0.61
KMT2A Q03164 2/20 0.46
ALOX15 P16050 1/20 0.46
BLM P54132 1/20 0.46
PMP22 Q01453 1/20 0.46
BIRC2 Q13490 1/20 0.41
FOLH1 Q04609 1/20 0.41
METAP2 P50579 6/20 0.38
METAP1 P53582 3/20 0.38
EED O75530 1/20 0.38
LNPEP Q9UIQ6 1/20 0.38
TSHR P16473 2/20 0.36
MEN1 O00255 1/20 0.36
CA14 Q9ULX7 1/20 0.36
MAPT P10636 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
CTSD P07339 1/20 0.35
BACE1 P56817 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27232991 0.88 DPP4 (0.59) DPP4DPP8DPP9BLMBIRC2
SCHEMBL29399286 0.88 DPP4 (0.59) DPP4DPP8DPP9BLMBIRC2
SCHEMBL27232992 0.88 DPP4 (0.59) DPP4DPP8DPP9BLMBIRC2
Hydrochloric Acid SCHEMBL23404047 0.87 DPP4 (0.58) DPP4DPP8DPP9BLMBIRC2
SCHEMBL2391827 0.87 DPP4 (0.51) DPP4DPP8DPP9KMT2AALOX15
SCHEMBL30799779 0.86 DPP8 (0.65) DPP4DPP8DPP9KMT2AALOX15
SCHEMBL3065655 0.84 DPP4 (0.63) DPP4DPP8DPP9KMT2AALOX15
SCHEMBL751144 0.84 DPP4 (0.63) DPP4DPP8DPP9KMT2AALOX15
SCHEMBL27436596 0.84 DPP4 (0.55) DPP4DPP8DPP9KMT2AALOX15
SCHEMBL27405539 0.83 BIRC2 (0.44) DPP4DPP8DPP9KMT2ABIRC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240398966-A1 CONJUGATES AND METHODS OF USING THE SAME FLAGSHIP PIONEERING INNOVATIONS V INC (US) 2024-12-05 US disclosed
US-11998610-B2 Conjugates and methods of using the same FLAGSHIP PIONEERING INNOVATIONS V, INC. (US) 2024-06-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11998610-B2 Conjugates and methods of using the same CD47, CD44, CD74 DPP4 1285/4885DPP8 693/4885DPP9 1086/4885
US-20240398966-A1 CONJUGATES AND METHODS OF USING THE SAME CD47, CD44, CD74 DPP4 1285/4885DPP8 693/4885DPP9 1086/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.